Trial · NCT02138747
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period 1 | STARTED | AB: Mirabegron/Tolterodine ER | 156 | |
| Treatment Period 1 | STARTED | BA: Tolterodine ER /Mirabegron | 157 | |
| Treatment Period 1 | STARTED | AA: Mirabegron/Mirabegron | 31 | |
| Treatment Period 1 | STARTED | BB: Tolterodine ER /Tolterodine ER | 32 | |
| Treatment Period 1 | COMPLETED | AB: Mirabegron/Tolterodine ER | 136 | |
| Treatment Period 1 | COMPLETED | BA: Tolterodine ER /Mirabegron | 132 | |
| Treatment Period 1 | COMPLETED | AA: Mirabegron/Mirabegron | 27 | |
| Treatment Period 1 | COMPLETED | BB: Tolterodine ER /Tolterodine ER | 28 | |
| Treatment Period 1 | NOT COMPLETED | AB: Mirabegron/Tolterodine ER | 20 | |
| Treatment Period 1 | NOT COMPLETED | BA: Tolterodine ER /Mirabegron | 25 | |
| Treatment Period 1 | NOT COMPLETED | AA: Mirabegron/Mirabegron | 4 | |
| Treatment Period 1 | NOT COMPLETED | BB: Tolterodine ER /Tolterodine ER | 4 | |
| Treatment Period 2 | STARTED | AB: Mirabegron/Tolterodine ER | 138 | |
| Treatment Period 2 | STARTED | BA: Tolterodine ER /Mirabegron | 132 | |
| Treatment Period 2 | STARTED | AA: Mirabegron/Mirabegron | 26 | |
| Treatment Period 2 | STARTED | BB: Tolterodine ER /Tolterodine ER | 27 | |
| Treatment Period 2 | COMPLETED | AB: Mirabegron/Tolterodine ER | 121 | |
| Treatment Period 2 | COMPLETED | BA: Tolterodine ER /Mirabegron | 125 | |
| Treatment Period 2 | COMPLETED | AA: Mirabegron/Mirabegron | 24 | |
| Treatment Period 2 | COMPLETED | BB: Tolterodine ER /Tolterodine ER | 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02138747/flow